EA201700114A1 - Капсаициноиды и их применение в качестве лекарственных средств - Google Patents

Капсаициноиды и их применение в качестве лекарственных средств

Info

Publication number
EA201700114A1
EA201700114A1 EA201700114A EA201700114A EA201700114A1 EA 201700114 A1 EA201700114 A1 EA 201700114A1 EA 201700114 A EA201700114 A EA 201700114A EA 201700114 A EA201700114 A EA 201700114A EA 201700114 A1 EA201700114 A1 EA 201700114A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drug
applicable
treatment
capsaicinoids
medicines
Prior art date
Application number
EA201700114A
Other languages
English (en)
Inventor
Мандишора Израиль Музари
Original Assignee
Мандишора Израиль Музари
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014903253A external-priority patent/AU2014903253A0/en
Application filed by Мандишора Израиль Музари filed Critical Мандишора Израиль Музари
Publication of EA201700114A1 publication Critical patent/EA201700114A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящем изобретении предложено лекарственное средство, содержащее капсаициноид, обладающее противовирусным действием и применимое для лечения вирусных инфекций и ВИЧ/СПИД. Лекарственное средство также обладает усиливающим нейропластичность действием и применимо для лечения стресса и других психологических состояний. Кроме того, лекарственное средство обладает противовоспалительным действием и применимо для лечения артрита. Лекарственное средство также обладает антибактериальным действием.
EA201700114A 2014-08-19 2015-07-31 Капсаициноиды и их применение в качестве лекарственных средств EA201700114A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014903253A AU2014903253A0 (en) 2014-08-19 Viral therapy
PCT/AU2015/000454 WO2016025977A1 (en) 2014-08-19 2015-07-31 Capsaicinoids and uses thereof as medicaments

Publications (1)

Publication Number Publication Date
EA201700114A1 true EA201700114A1 (ru) 2017-06-30

Family

ID=55349992

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201700114A EA201700114A1 (ru) 2014-08-19 2015-07-31 Капсаициноиды и их применение в качестве лекарственных средств

Country Status (8)

Country Link
US (1) US20170239198A1 (ru)
EP (1) EP3182968A4 (ru)
KR (1) KR20170066344A (ru)
AU (1) AU2015306063A1 (ru)
CA (1) CA2961766A1 (ru)
EA (1) EA201700114A1 (ru)
MA (1) MA40496A (ru)
WO (1) WO2016025977A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3534961A4 (en) 2016-11-02 2020-05-27 Centrexion Therapeutics Corporation STABLE AQUEOUS INJECTABLE CAPSAICIN FORMULATIONS AND MEDICAL USES THEREOF
CN111201015A (zh) 2017-07-20 2020-05-26 中枢疗法公司 使用辣椒素治疗疼痛的方法和组合物
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) * 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US20030082249A1 (en) * 2001-10-26 2003-05-01 Ovation Pharmaceuticals Compositions containing capsaicin and its derivatives, and their use in treating mucositis
FR2849992B1 (fr) * 2003-01-17 2007-03-16 Inst Phytoceutic Composition pour une administration par voie orale contenant des capsaicinoides
US20040224037A1 (en) * 2003-04-28 2004-11-11 Gonzalo Romero-Matos Devastating treatment against hiv/aids with capsaicin

Also Published As

Publication number Publication date
MA40496A (fr) 2017-06-28
US20170239198A1 (en) 2017-08-24
AU2015306063A1 (en) 2017-04-13
EP3182968A4 (en) 2018-05-09
CA2961766A1 (en) 2016-02-25
WO2016025977A1 (en) 2016-02-25
EP3182968A1 (en) 2017-06-28
KR20170066344A (ko) 2017-06-14

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
EA201890204A1 (ru) Антибактериальные соединения
EA202091898A1 (ru) Антитела, нейтрализующие вирус иммунодефицита человека
EA201990043A1 (ru) Антибактериальные соединения
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
DK3191502T3 (da) Målrettet indgivelse af tertiært aminholdige lægemiddelstoffer
MX2020005187A (es) Compuestos y composiciones farmaceuticas antivirales, asi como metodos de uso de los mismos.
PH12016500486A1 (en) Aza-pyridone compounds and uses thereof
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
EA201691582A1 (ru) Новые фармацевтические препараты
BR112015024411A2 (pt) desaza-purinonas macrocíclicas para o tratamento de infeções virais
IL263368A (en) Prevention and treatment of viral infections
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
IL256327B (en) Pharmaceutical preparations for the treatment of viral problems of the eye
EA201700114A1 (ru) Капсаициноиды и их применение в качестве лекарственных средств
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
BR112017023425A2 (pt) combinações terapêuticas de terapias antivirais e anti-inflamatórias
IN2014MU00916A (ru)
EA201890653A1 (ru) Композиция с противовирусным эффектом
CL2015003752A1 (es) Inhibidores de replicación viral, su proceso de preparación y sus uso terapeutico
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
DK2991664T3 (da) Midler til forebyggelse og behandling af følgesygdomme af HIV og andre virusinfektioner
EA201700254A1 (ru) Комбинация
CR20170191A (es) Composiciones farmacéuticas de acción prolongada para la hepatitis c